© Crown copyright 2017
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: email@example.com.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/public-health-england-phe-research-involving-animals/public-health-england-research-involving-animals
Public Health England (PHE) and Porton Biopharma Limited (PBL) have joined over 130 research organisations and universities in the UK committed to being more transparent with the public about when, how and why we use animals in our research.
How and why we use animals
Our primary duty is to protect the public’s health from infectious disease and other public health hazards. We maintain an active programme to replace, refine and reduce the use of animals in our research (the 3 Rs). The use of any animal is not undertaken lightly. However, while not all research results in new diagnostics and treatments, it nonetheless plays a critical role in developing both the basic and applied scientific knowledge that is crucial for health protection and medical advances.
The vast majority of PHE’s scientific research does not involve animals but the biological similarities between humans and other species means that they can, on some occasions, be the only effective model for research into infectious and other diseases where the response to infection or vaccination is too complex to be modelled in any other way. Some examples of this are to:
- support the development of new vaccines or therapies for key public health threats and emerging or re-emerging diseases, including: influenza, HIV-AIDS, tuberculosis, hepatitis C, meningococcal disease, neonatal sepsis, Clostridium difficile, Zika and Ebola
- improve methods of diagnosis of new and emerging pathogens
- develop tools for quickly identifying the severity of flu
- maintain a robust system for access to immunoglobulin and antitoxins for the prevention and treatment of infectious disease
- identify chemical and radiation hazards
- improve management of casualties in acute radiation and chemical incidents
We use a small range of animal species in our research such as mice, ferrets, guinea pigs, hamsters and non-human primates, which are selected on the basis that the model chosen gives most clinical relevance to our research. In cases where their use is essential in public health research and biopharmaceutical research and development, and production, we are committed to ensuring that all animals in our care are treated with full respect, and that all staff involved with this work show due consideration at every level.
How we operate
Our work is overseen by local ethical committees and we operate within a strict regulatory regime overseen by the Home Office, whose inspectors have free and unfettered access to our scientific campuses. Each of our 3 scientific campuses holds a Home Office licence that allows animal research. A system of project and personal licences requires that each programme of work and individual research scientist working with animals has approval from the Home Office to do so.
When planning research, our scientists always consider alternatives to animals such as computer models and working on cells in the lab. They look for different methods that can replace animal research or reduce the numbers of animals involved, and they search for ways to modify their methods to improve animal welfare. Researchers will only proceed when an alternative cannot be found. Every opportunity is taken to maximise the information gained from each experiment and a substantial archive of stored blood samples and tissues means that up to date tests that include genomics and proteomics can be applied to gain new information without using more animals.
Scientists who work with animals are supported by a team of expert staff with veterinary and technical skills so that experiments are conducted to the highest standards of animal welfare. Animals are housed in specially designed units where they can live comfortably. Staff training and facilities are all designed to improve animal welfare.
Proposed new research and alterations to ongoing research are examined by an ethics committee made up of a variety of people including vets, animal technicians, scientists, and lay people who are not directly involved in animal research and can bring a fresh perspective to the consideration of research proposals. Ethics committees discuss the merits and details of proposed research and question whether alternative methods could be used before they approve the work to go ahead.
Over 99% of animal research at PHE involves mice, hamsters, guinea pigs, ferrets, rabbits, turkeys and rats. The remainder, less than 1%, involves non-human primates. All animals are obtained from Home Office approved breeders and suppliers.
Number of animals used
The following tables provide the numbers of animals used, per species, at our scientific campuses at Porton, Colindale and Chilton, from 2014 to 2016.
PHE Porton (includes Porton Biopharma Limited)
|Year||Mice||Hamsters||Ferrets||Guinea pigs||Rabbits||Non-human primates (NHP)|
The research includes studies that help us understand the body’s response to disease. For example, ferrets are used as models to study diseases caused by influenza viruses as their respiratory system has many similarities to that of humans.
Hamsters are the model of choice for Clostridium difficile (C.diff) infection and work has led to the clinical application of new treatments against this highly infectious disease that affects many hospital patients. Non-human primates are used only when other species are considered not to be suitable and are typically used where a therapy or vaccine is near to use in the clinic due to their close similarity to human immunology and physiology. In the majority of cases, the procedures conducted are of minimal impact on animal welfare and involve vaccination in the same way that humans are immunised.
PBL’s work is focussed on quality-assured development of biopharmaceuticals including Erwinase, a childhood leukaemia therapy, and the UK’s anthrax vaccine and their work mainly involves the use of guinea pigs and mice.
The use of rabbits for enteric antisera work has been discontinued and replaced with whole genome sequencing technology.
PHE Chilton (Centre for Radiation, Chemical and Environmental Hazards)
The research includes the study of radiation-induced acute myeloid leukaemia and intestinal cancer, and responses to toxic stress caused by chemicals or nanoparticles, and the neurobiological effects of electromagnetic fields.